New Resource Saves Drug Developers
Time and Money
|
| In the pharma industry, speed is of the essence. The Patheon OneSource™ model exemplifies the benefits of an end-to-end supply chain for pharma and biopharma clients by accelerating time to clinic and to market, adding cost savings, and putting formulations on the path to regulatory success. Following a CPhI North America panel on single-vendor CDMOs, PharmTech spoke with Anil Kane, PhD, executive director and global head of technical and scientific affairs at Patheon, to talk about his views on the subject. |
|
|
|
|
A Single-Vendor CDMA Eases Communication Flow
|
| A single vendor offers access to a network of experts across several disciplines who can share knowledge about a project as it moves from phase to phase, thus helping to navigate its path toward commercial success. Following a CPhI North America panel about single-source CDMOs, Pharmaceutical Technology spoke with Paul Nelson, vice president of supply chain and R&D at Amring Pharmaceuticals, about his experience with single-source CDMOs. |
|
|
|
|
|
